|
業務類別
|
Biotechnology |
|
業務概覽
|
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production. |
| 公司地址
| Hadassah Ein Kerem Campus, 2nd Floor, Jerusalem BioPark, Jerusalem, ISR |
| 電話號碼
| +972 89302529 |
| 傳真號碼
| +972 89302531 |
| 公司網頁
| https://www.scinai.com |
| 員工數量
| 45 |
| Mr. Amir Reichman |
Chief Executive Officer and Director |
美元 342.00K |
01/04/2026 |
| Mr. Elad Mark |
Chief Operating Officer |
美元 175.00K |
01/04/2026 |
| Mr. Uri Ben-Or, C.P.A.,M.B.A. |
Chief Financial Officer |
美元 165.00K |
01/04/2026 |
|
|
| Mr. Amir Reichman |
Chief Executive Officer and Director |
01/04/2026 |
| Mr. Adi Raviv |
Independent Director |
01/04/2026 |
| Mr. Mark Germain |
Chairman of the Board |
01/04/2026 |
| Dr. Yael Margolin, M.Sc.,PhD |
Independent Director |
01/04/2026 |
| Mr. Jay Green, C.A.,C.P.A. |
Independent Director |
01/04/2026 |
| Mr. Samuel J. Moed |
Director |
01/04/2026 |
|
|
|
|
